SAN FRANCISCO--(BUSINESS WIRE)--Ventracor (ASX:VCR) announced today the presentation of summary clinical data of the first 100 patients implanted with the VentrAssist™ third generation left ventricular assist device (LVAD), an implantable blood pump designed for long term use in patients with advanced heart failure.
